Publications by authors named "John F MacMaster"

Claim this Profile
S
Synthesis and biological evaluation of 4-amino derivatives of benzimidazoquinoxaline, benzimidazoquinoline, and benzopyrazoloquinazoline as potent IKK inhibitors.
Francis Beaulieu, Carl Ouellet, Edward H Ruediger, Makonen Belema, Yuping Qiu, John F MacMaster

Bioorg Med Chem Lett· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Collagen and aggrecan degradation is blocked in interleukin-1-treated cartilage explants by an inhibitor of IkappaB kinase through suppression of metalloproteinase expression.
Mark A Pattoli, John F MacMaster, Kurt R Gregor, James R Burke

J Pharmacol Exp Ther· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice.
James R Burke, Mark A Pattoli, Kurt R Gregor, Patrick J Brassil, John F MacMaster

J Biol Chem· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reductively activated disulfide prodrugs of paclitaxel.
Vivekananda M Vrudhula, John F MacMaster, Zhengong Li, David E Kerr, Peter D Senter

Bioorg Med Chem Lett· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of N-[2-[2-[[3-methoxy-4-(5-oxazolyl)phenyl]amino]-5-oxazolyl]phenyl]-N-methyl-4- morpholineacetamide as a novel and potent inhibitor of inosine monophosphate dehydrogenase with excellent in vivo activity.
T G Murali Dhar, Zhongqi Shen, Junqing Guo, Chunjian Liu, Scott H Watterson, John F MacMaster

J Med Chem· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis